Hosted on MSN2mon
Capricor completes U.S. marketing submission for lead candidateCell therapy developer Capricor Therapeutics (NASDAQ:CAPR) announced Thursday the completion of the U.S. marketing application for its lead candidate, deramiocel, for patients with Duchenne ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback